These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 24618374)
1. The failure of cancer chemoprevention. Potter JD Carcinogenesis; 2014 May; 35(5):974-82. PubMed ID: 24618374 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colorectal cancer. Das D; Arber N; Jankowski JA Digestion; 2007; 76(1):51-67. PubMed ID: 17947819 [TBL] [Abstract][Full Text] [Related]
3. Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. Singh DK; Lippman SM Oncology (Williston Park); 1998 Dec; 12(12):1787-800; discussion 1802, 1805. PubMed ID: 9874850 [TBL] [Abstract][Full Text] [Related]
4. Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Meyskens FL; Szabo E Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1366-9. PubMed ID: 15941942 [TBL] [Abstract][Full Text] [Related]
5. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials. Greenwald P J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colorectal cancer. Gwyn K; Sinicrope FA Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936 [TBL] [Abstract][Full Text] [Related]
8. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II. Moyad MA Urol Oncol; 2004; 22(6):472-7. PubMed ID: 15610864 [TBL] [Abstract][Full Text] [Related]
10. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I. Moyad MA Urol Oncol; 2004; 22(6):466-71. PubMed ID: 15610863 [TBL] [Abstract][Full Text] [Related]
11. Rationale and strategies for chemoprevention of cancer in humans. Bertram JS; Kolonel LN; Meyskens FL Cancer Res; 1987 Jun; 47(11):3012-31. PubMed ID: 3105872 [TBL] [Abstract][Full Text] [Related]
12. Update on prostate cancer chemoprevention. Lowe JF; Frazee LA Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715 [TBL] [Abstract][Full Text] [Related]
14. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Lippman SM; Lee JJ Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634 [TBL] [Abstract][Full Text] [Related]
15. Serum retinoids and beta-carotene as predictors of hip and other fractures in elderly women. Barker ME; McCloskey E; Saha S; Gossiel F; Charlesworth D; Powers HJ; Blumsohn A J Bone Miner Res; 2005 Jun; 20(6):913-20. PubMed ID: 15883630 [TBL] [Abstract][Full Text] [Related]
16. Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Singh DK; Lippman SM Oncology (Williston Park); 1998 Nov; 12(11):1643-53, 1657-8; discussion 1659-60. PubMed ID: 9834941 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of cancer: review of the literature. Swan DK; Ford B Oncol Nurs Forum; 1997 May; 24(4):719-27. PubMed ID: 9159786 [TBL] [Abstract][Full Text] [Related]
18. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Drake EN Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336 [TBL] [Abstract][Full Text] [Related]